1. FDA. Guidance for Industry: Bioavailability and Bioequivalence, Studies for Orally Administered Drug Products - General Considerations. In: (CDER) CfDEaR, editor. 2003.
2. Comparing generic and innovator drugs: a review of 12 years of bioequivalence data from the United States Food and Drug Administration;Davit;Ann Pharmacother,2009
3. The bioequivalence and therapeutic efficacy of generic versus brand-name psychoactive drugs;Borgheini;Clin Ther,2003
4. MINSAL. DTO. N° 1876- Reglamento del Sistema Nacional de Control de Productos Farmaceuticos. 1995.
5. MINSAL. Resolución Exenta nro. 726 - Listas de Principios Activos Contenidos en Productos Farmaceuticos que Deben Establecer Equivalencia Terapeutica Mediante Estudios In Vivo o In Vitro. 2005.